Immune-mediated thrombocytopenia (IMT) is a common disease in dogs. Primary IMT is idiopathic, while secondary IMT can result from a variety of infectious agents or some treatments. Symptoms may include lethargy, anorexia and mild pyrexia, together with a low platelet count and associated bleeding disorders. Prognosis is generally positive, but reduced with presence of melena or raised blood urea nitrogen. Treatment will include some form of immunosuppressive therapy, such as prednisolone, which can have multiple side effects. Nursing the IMT patient will aim at monitoring and reducing spontaneous haemorrhage and managing treatment side effects. To ensure owner understanding and compliance, it is vital to discuss these side effects and any appropriate home adjustments so an achievable plan can be developed for home care.
- canine immune-mediated thrombocytopenia
- platelet count
- veterinary nursing
- immunosuppressive therapy